found to be absorbed systemically,1-4 it might be expected that adrenaline infused into the posterior segment may similarly be absorbed.
give rise to unwanted cardiovascular effects.
We sought to establish whether significant amounts of adrenaline are systemically absorbed. found to be absorbed systemically,1-4 it might be expected that adrenaline infused into the posterior segment may similarly be absorbed.
Methods
As well as the routes by which topical adrenaline may be absorbed there is the potential for further absorption occurring via the ciliary body, iris and choroidal vasculature.
We aimed to find out whether there was significant absorption of administered adrenaline.
The study followed the tenets of the Helsinki muscular paralysis, as demonstrated by the loss of a train of four nerve stimulations, tracheal intubation was performed. Anaesthesia was maintained using intermittent positive pressure ventilation with a combination of 66% nitrous oxide and 33% oxygen whilst enflurane was maintained between 0.5% and 2% to keep pulse and blood pressure within normal limits. End-tidal carbon dioxide was maintained between 4.0% and 4.4%.
Peripheral venous blood samples were taken at the following intervals: prior to induction of anaesthesia, 5 min following intubation, and at 5, 10, 15 and 30 min following the commencement of infusion. Samples were placed without delay into lithium heparin tubes containing the anti-oxidant sodium metabisulphite and immediately cooled on ice for 5 min before being centrifuged at 3000 r.p.m. The serum was separated with a pipette and placed in a plain tube on ice for a maximum of 2 h before being frozen to -15°C. Samples were stored for a maximum of 1 month before assay for adrenaline levels using high-performance liquid chromatography with an ESA Coulochem electrochemical detector.
Patients had pulse, blood pressure and electrocardiograms monitored at 3 min intervals from the pre-induction stage. The timings of the blood samples were recorded and the total volume of posterior segment infusion was recorded at each sampling time.
Comparisons of adrenaline levels between the two groups were made using Wilcoxon's signed rank test.
Results
Ten patients were studied. Six patients were randomised to the Hs+Ad group and four the the Hs group. The mean age in the Hs+Ad group was 61.3 years (range 39-90 years) with a male-to-female ratio of 2:1. ( Table 1 ).
Serum adrenaline levels at the various sampling times are shown for both groups in Table 2 . The maximum coefficient of variation for adrenaline levels below 1 nmol/l using the Coulochem detector was 8%.
Adrenaline levels follow a non-Gaussian distribution due to the lowest sensitivity of the assay being 0. There was no statistical difference between adrenaline levels prior to induction or following intubation and subsequent post-infusion levels in either group. There was no significant change in adrenaline level associated with changes in infusion rate throughout the procedure.
Furthermore there was no detectable association between We did not detect any significant changes in pulse rate or blood pressure that could be attributed to the adrenaline infusion and there were no detected incidences of cardiac dysrhythmia. Due to the standardisation of the anaesthetic by parameters that included pulse and blood pressure little relevance can be applied to these particular findings. We conclude from this study that there is no significant absorption of adrenaline when infused through the posterior segment at the described rates and concentrations. Adverse reactions to adrenaline may, however, be idiosyncratic.4 Continued caution must be exercised when using this drug in posterior segment infusion during vitreoretinal surgery.
